GENZYME CORP's ticker is GENZ and the CUSIP is 372917104. A total of 3 filers reported holding GENZYME CORP in Q3 2010. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2011 | $388,467 | +26.9% | 5,100 | +18.6% | 0.16% | +3.2% |
| Q4 2010 | $306,160 | -18.4% | 4,300 | -18.9% | 0.16% | -27.8% |
| Q3 2010 | $375,187 | +39.4% | 5,300 | 0.0% | 0.22% | +25.6% |
| Q2 2010 | $269,081 | +36.6% | 5,300 | +39.5% | 0.17% | +35.4% |
| Q1 2010 | $196,954 | +5.8% | 3,800 | 0.0% | 0.13% | +1.6% |
| Q4 2009 | $186,238 | -28.6% | 3,800 | -17.4% | 0.12% | -23.8% |
| Q3 2009 | $260,958 | +1.9% | 4,600 | 0.0% | 0.16% | -14.6% |
| Q2 2009 | $256,082 | +7.2% | 4,600 | +27.8% | 0.19% | -17.9% |
| Q4 2008 | $238,932 | +1.9% | 3,600 | +24.1% | 0.23% | +13.0% |
| Q3 2008 | $234,581 | -27.6% | 2,900 | -35.6% | 0.21% | -8.8% |
| Q2 2008 | $324,090 | +49.9% | 4,500 | +55.2% | 0.23% | +18.8% |
| Q1 2008 | $216,166 | +0.1% | 2,900 | 0.0% | 0.19% | +10.4% |
| Q4 2007 | $215,876 | +93.6% | 2,900 | +61.1% | 0.17% | +78.4% |
| Q3 2007 | $111,528 | -3.8% | 1,800 | 0.0% | 0.10% | -4.9% |
| Q2 2007 | $115,920 | +7.3% | 1,800 | 0.0% | 0.10% | +1.0% |
| Q1 2007 | $108,036 | -2.5% | 1,800 | 0.0% | 0.10% | +3.1% |
| Q4 2006 | $110,844 | – | 1,800 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rehmann Capital Advisory Group | 4,317 | $240,000 | 0.20% |
| E. Ohman J:or Asset Management AB | 4,600 | $256,082 | 0.19% |
| HUNTINGTON NATIONAL BANK | 51,694 | $2,878,000 | 0.15% |
| RATIONAL ADVISORS LLC | 9,100 | $507,000 | 0.06% |